Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 2/2018

01-04-2018 | Research Article

Drug related problems identified by clinical pharmacist at the Internal Medicine Ward in Turkey

Authors: Nibal Abunahlah, Anfal Elawaisi, Fatih Mehmet Velibeyoglu, Mesut Sancar

Published in: International Journal of Clinical Pharmacy | Issue 2/2018

Login to get access

Abstract

Background Drug-related problems (DRPs) interfere with patient optimal therapeutic outcomes and may be associated with higher morbidity, mortality and healthcare expenditures. Objective This study aimed to identify DRPs and their causes in a Turkish hospital. Setting Bakirkoy Dr. Sadi Konuk Teaching and Research Hospital, Internal Medicine Ward, Istanbul, Turkey. Method Cross-sectional study included a total of 100 patients. Patient demographics, medications, and history were evaluated. Data regarding recent medications were analyzed by two clinical pharmacists and an Internal Medicine physician. The DRPs were identified via V7.0 PCNE classification. Lexicomp® was used to assess the drug–drug interactions. UpToDate® recommendations and national guidelines were applied in the assessment of compliance with approved medication procedures. Main outcome measures Number and causes of the potential DRPs. Results At least one potential DRP was seen in 80% of the patients and 163 potential DRPs were identified (average = 1.6 DRPs/patient). The most common causes of DRPs were errors in drug selection (44.78%), dose selection (27.61%) and medication procedures (21.47%). There were significant correlations (p < 0.05) between DRPs and age (r = 0.4), number of drugs used (r = 0.32), duration of hospitalization (r = 0.25), renal impairment (r = − 0.34) and inflammation (r = 0.31). Conclusion The majority of the patients had DRPs. Patients with renal impairment, inflammation, polypharmacy or an extended hospital stay had a much higher chance of developing DRPs.
Literature
1.
go back to reference Adusumilli PK, Adepu R. Drug related problems: an overview of various classification systems. Asian J Pharm Clin Res. 2014;7:7–10. Adusumilli PK, Adepu R. Drug related problems: an overview of various classification systems. Asian J Pharm Clin Res. 2014;7:7–10.
2.
go back to reference van den Bemt PM, Egberts TC, Brouwers JR. Drug-related problems in hospitalised patients. Drug Saf. 2000;22:321–33.CrossRefPubMed van den Bemt PM, Egberts TC, Brouwers JR. Drug-related problems in hospitalised patients. Drug Saf. 2000;22:321–33.CrossRefPubMed
3.
go back to reference Krähenbühl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krähenbühl S. Drug-related problems in hospitals. Drug Saf. 2007;30:379–407.CrossRefPubMed Krähenbühl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krähenbühl S. Drug-related problems in hospitals. Drug Saf. 2007;30:379–407.CrossRefPubMed
4.
go back to reference Strand LM, Morley PC, Cipolle RJ, Ramsey R, Lamsam GD. Drug-related problems: their structure and function. Dicp Ann Pharmac. 1990;24:1093–7. Strand LM, Morley PC, Cipolle RJ, Ramsey R, Lamsam GD. Drug-related problems: their structure and function. Dicp Ann Pharmac. 1990;24:1093–7.
5.
go back to reference Kaufmann CP, Stämpfli D, Hersberger KE, Lampert ML. Determination of risk factors for drug-related problems: a multidisciplinary triangulation process. BMJ Open. 2015;5:e006376.CrossRefPubMedPubMedCentral Kaufmann CP, Stämpfli D, Hersberger KE, Lampert ML. Determination of risk factors for drug-related problems: a multidisciplinary triangulation process. BMJ Open. 2015;5:e006376.CrossRefPubMedPubMedCentral
6.
go back to reference Blix HS, Viktil KK, Reikvam Å, Moger TA, Hjemaas BJ, Pretsch P, Vraalsen TF, Walseth EK. The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals. Eur J Clin Pharmacol. 2004;60:651–8.CrossRefPubMed Blix HS, Viktil KK, Reikvam Å, Moger TA, Hjemaas BJ, Pretsch P, Vraalsen TF, Walseth EK. The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals. Eur J Clin Pharmacol. 2004;60:651–8.CrossRefPubMed
7.
go back to reference Committee C. Third consensus of granada in drug related problems (DRP) and negative outcomes associated with medication (NOM). Ars Pharm. 2007;48:5–17. Committee C. Third consensus of granada in drug related problems (DRP) and negative outcomes associated with medication (NOM). Ars Pharm. 2007;48:5–17.
8.
go back to reference Huri HZ, Wee HF. Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective study. BMC Endocr Disord. 2013;13:2.CrossRef Huri HZ, Wee HF. Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective study. BMC Endocr Disord. 2013;13:2.CrossRef
9.
go back to reference Leendertse AJ, Egberts AC, Stoker LJ, van den Bemt PM. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008;168:1890–6.PubMed Leendertse AJ, Egberts AC, Stoker LJ, van den Bemt PM. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008;168:1890–6.PubMed
10.
go back to reference Lien LL, Lien EJ. Preventing potential drug interactions in community pharmacy. J Clin Pharm Ther. 1994;19:371–9.CrossRefPubMed Lien LL, Lien EJ. Preventing potential drug interactions in community pharmacy. J Clin Pharm Ther. 1994;19:371–9.CrossRefPubMed
11.
go back to reference Rashed AN, Neubert A, Alhamdan H, Tomlin S, Alazmi A, AlShaikh A, Wilton L, Wong IC. Drug-related problems found in children attending an emergency department in Saudi Arabia and in the United Kingdom. Int J Clin Pharm. 2013;35(3):327–31.CrossRefPubMed Rashed AN, Neubert A, Alhamdan H, Tomlin S, Alazmi A, AlShaikh A, Wilton L, Wong IC. Drug-related problems found in children attending an emergency department in Saudi Arabia and in the United Kingdom. Int J Clin Pharm. 2013;35(3):327–31.CrossRefPubMed
12.
go back to reference Richardson TE, O’Reilly CL, Chen TF. Drug-related problems and the clinical role of pharmacists in inpatient mental health: an insight into practice in Australia. Int J Clin Pharm. 2014;36:1077–86.CrossRefPubMed Richardson TE, O’Reilly CL, Chen TF. Drug-related problems and the clinical role of pharmacists in inpatient mental health: an insight into practice in Australia. Int J Clin Pharm. 2014;36:1077–86.CrossRefPubMed
13.
go back to reference Alsulami Z, Conroy S, Choonara I. Medication errors in the Middle East countries: a systematic review of the literature. Eur J Clin Pharmacol. 2013;69:995–1008.CrossRefPubMed Alsulami Z, Conroy S, Choonara I. Medication errors in the Middle East countries: a systematic review of the literature. Eur J Clin Pharmacol. 2013;69:995–1008.CrossRefPubMed
14.
go back to reference Viktil KK, Blix HS. The impact of clinical pharmacists on drug-related problems and clinical outcomes. Basic Clin Pharmacol Toxicol. 2008;102:275–80.CrossRefPubMed Viktil KK, Blix HS. The impact of clinical pharmacists on drug-related problems and clinical outcomes. Basic Clin Pharmacol Toxicol. 2008;102:275–80.CrossRefPubMed
15.
go back to reference Basger BJ, Moles RJ, Chen TF. Application of drug-related problem (DRP) classification systems: a review of the literature. Eur J Clin Pharmacol. 2014;70:799–815.CrossRefPubMed Basger BJ, Moles RJ, Chen TF. Application of drug-related problem (DRP) classification systems: a review of the literature. Eur J Clin Pharmacol. 2014;70:799–815.CrossRefPubMed
16.
go back to reference Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, Cohen HJ, Feussner JR. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45(10):1045–51.CrossRefPubMed Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, Cohen HJ, Feussner JR. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45(10):1045–51.CrossRefPubMed
22.
go back to reference Halvorsen KH, Ruths S, Granas AG, Viktil KK. Multidisciplinary intervention to identify and resolve drug-related problems in Norwegian nursing homes. Scan J Prim Health Care. 2010;28:82–8.CrossRef Halvorsen KH, Ruths S, Granas AG, Viktil KK. Multidisciplinary intervention to identify and resolve drug-related problems in Norwegian nursing homes. Scan J Prim Health Care. 2010;28:82–8.CrossRef
23.
go back to reference Lampert ML, Kraehenbuehl S, Hug BL. Drug-related problems: evaluation of a classification system in the daily practice of a Swiss University Hospital. Pharm World Sci. 2008;30:768–76.CrossRefPubMed Lampert ML, Kraehenbuehl S, Hug BL. Drug-related problems: evaluation of a classification system in the daily practice of a Swiss University Hospital. Pharm World Sci. 2008;30:768–76.CrossRefPubMed
24.
go back to reference Ruths S, Straand J, Nygaard HA. Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study. Qual Saf Health Care. 2003;12:176–80.CrossRefPubMedPubMedCentral Ruths S, Straand J, Nygaard HA. Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study. Qual Saf Health Care. 2003;12:176–80.CrossRefPubMedPubMedCentral
25.
go back to reference Al-Azzam SI, Alzoubi KH, AbuRuz S, Alefan Q. Drug-related problems in a sample of outpatients with chronic diseases: a cross-sectional study from Jordan. Ther Clin Risk Manag. 2016;12:233.CrossRefPubMedPubMedCentral Al-Azzam SI, Alzoubi KH, AbuRuz S, Alefan Q. Drug-related problems in a sample of outpatients with chronic diseases: a cross-sectional study from Jordan. Ther Clin Risk Manag. 2016;12:233.CrossRefPubMedPubMedCentral
26.
go back to reference Ayalew MB, Megersa TN, Mengistu YT. Drug-related problems in medical wards of Tikur Anbessa specialized hospital, Ethiopia. J Res Pharm Pract. 2015;4:216.CrossRefPubMedPubMedCentral Ayalew MB, Megersa TN, Mengistu YT. Drug-related problems in medical wards of Tikur Anbessa specialized hospital, Ethiopia. J Res Pharm Pract. 2015;4:216.CrossRefPubMedPubMedCentral
27.
go back to reference Ciapponi A, Pizarro R, Harrison J. Trimetazidine for stable angina. Cochrane Database Syst Rev. 2005;4:CD003614. Ciapponi A, Pizarro R, Harrison J. Trimetazidine for stable angina. Cochrane Database Syst Rev. 2005;4:CD003614.
29.
go back to reference Ponte ML, Keller GA, Girolamo GD. Mechanisms of drug induced QT interval prolongation. Curr Drug Saf. 2010;5:44–53.CrossRefPubMed Ponte ML, Keller GA, Girolamo GD. Mechanisms of drug induced QT interval prolongation. Curr Drug Saf. 2010;5:44–53.CrossRefPubMed
30.
go back to reference Lenssen R, Heidenreich A, Schulz JB, Trautwein C, Fitzner C, Jaehde U, Eisert A. Analysis of drug-related problems in three departments of a German University hospital. Int J Clin Pharm. 2016;38:119–26.CrossRefPubMed Lenssen R, Heidenreich A, Schulz JB, Trautwein C, Fitzner C, Jaehde U, Eisert A. Analysis of drug-related problems in three departments of a German University hospital. Int J Clin Pharm. 2016;38:119–26.CrossRefPubMed
33.
go back to reference Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM Jr, Musher DM, Niederman MS, Torres A. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;1(44 Suppl 2):S27–72.CrossRef Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM Jr, Musher DM, Niederman MS, Torres A. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;1(44 Suppl 2):S27–72.CrossRef
34.
go back to reference Huri HZ, Ling LC. Drug-related problems in type 2 diabetes mellitus patients with dyslipidemia. BMC Public Health. 2013;13:1192.CrossRef Huri HZ, Ling LC. Drug-related problems in type 2 diabetes mellitus patients with dyslipidemia. BMC Public Health. 2013;13:1192.CrossRef
36.
go back to reference Chan DC, Chen JH, Kuo HK, We CJ, Lu IS, Chiu LS, Wu SC. Drug-related problems (DRPs) identified from geriatric medication safety review clinics. Arch Gerontol Geriatr. 2012;54:168–74.CrossRefPubMed Chan DC, Chen JH, Kuo HK, We CJ, Lu IS, Chiu LS, Wu SC. Drug-related problems (DRPs) identified from geriatric medication safety review clinics. Arch Gerontol Geriatr. 2012;54:168–74.CrossRefPubMed
37.
go back to reference Koh Y, Kutty FB, Li SC. Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender. Ther Clin Risk Manag. 2005;1(1):39.CrossRefPubMedPubMedCentral Koh Y, Kutty FB, Li SC. Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender. Ther Clin Risk Manag. 2005;1(1):39.CrossRefPubMedPubMedCentral
38.
go back to reference Nelson KM, Talbert RL. Drug-related hospital admissions. Pharmacother J Hum Pharmacol Drug Ther. 1996;16:701–7. Nelson KM, Talbert RL. Drug-related hospital admissions. Pharmacother J Hum Pharmacol Drug Ther. 1996;16:701–7.
39.
go back to reference Viktil KK, Blix HS, Moger TA, Reikvam A. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol. 2007;63:187–95.CrossRefPubMed Viktil KK, Blix HS, Moger TA, Reikvam A. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol. 2007;63:187–95.CrossRefPubMed
40.
go back to reference Gustafsson M, Sjölander M, Pfister B, Jonsson J, Schneede J, Lövheim H. Drug-related hospital admissions among old people with dementia. Eur J Clin Pharmacol. 2016;72:1143–53.CrossRefPubMed Gustafsson M, Sjölander M, Pfister B, Jonsson J, Schneede J, Lövheim H. Drug-related hospital admissions among old people with dementia. Eur J Clin Pharmacol. 2016;72:1143–53.CrossRefPubMed
41.
go back to reference Moura CS, Acurcio FD, Belo ND. Drug–drug interactions associated with length of stay and cost of hospitalization. J Pharm Pharm Sci. 2009;12:266–72.CrossRefPubMed Moura CS, Acurcio FD, Belo ND. Drug–drug interactions associated with length of stay and cost of hospitalization. J Pharm Pharm Sci. 2009;12:266–72.CrossRefPubMed
43.
go back to reference Cryer B, Kimmey MB. Gastrointestinal side effects of nonsteroidal anti-inflammatory drugs. Am J Med. 1998;105:20S–30S.CrossRefPubMed Cryer B, Kimmey MB. Gastrointestinal side effects of nonsteroidal anti-inflammatory drugs. Am J Med. 1998;105:20S–30S.CrossRefPubMed
44.
go back to reference LaFleur J, McBeth C, Gunning K, Oderda L, Steinvoort C, Oderda GM. Prevalence of drug-related problems and cost-savings opportunities in medicaid high utilizers identified by a pharmacist-run drug regimen review center. J Manag Care Pharm. 2006;12:677–85.PubMed LaFleur J, McBeth C, Gunning K, Oderda L, Steinvoort C, Oderda GM. Prevalence of drug-related problems and cost-savings opportunities in medicaid high utilizers identified by a pharmacist-run drug regimen review center. J Manag Care Pharm. 2006;12:677–85.PubMed
Metadata
Title
Drug related problems identified by clinical pharmacist at the Internal Medicine Ward in Turkey
Authors
Nibal Abunahlah
Anfal Elawaisi
Fatih Mehmet Velibeyoglu
Mesut Sancar
Publication date
01-04-2018
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 2/2018
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-017-0585-5

Other articles of this Issue 2/2018

International Journal of Clinical Pharmacy 2/2018 Go to the issue